ASTRAZENECA PLC (ZEG.DE) Fundamental Analysis & Valuation
FRA:ZEG • GB0009895292
Current stock price
160.7 EUR
+0.95 (+0.59%)
Last:
This ZEG.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ZEG.DE Profitability Analysis
1.1 Basic Checks
- ZEG had positive earnings in the past year.
- ZEG had a positive operating cash flow in the past year.
- Each year in the past 5 years ZEG has been profitable.
- In the past 5 years ZEG always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of ZEG (8.96%) is better than 63.64% of its industry peers.
- Looking at the Return On Equity, with a value of 21.01%, ZEG is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
- ZEG has a Return On Invested Capital of 13.63%. This is in the better half of the industry: ZEG outperforms 65.45% of its industry peers.
- ZEG had an Average Return On Invested Capital over the past 3 years of 12.48%. This is below the industry average of 14.78%.
- The 3 year average ROIC (12.48%) for ZEG is below the current ROIC(13.63%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 21.01% | ||
| ROIC | 13.63% |
ROA(3y)7.2%
ROA(5y)5.03%
ROE(3y)17.82%
ROE(5y)12.53%
ROIC(3y)12.48%
ROIC(5y)10.5%
1.3 Margins
- ZEG has a better Profit Margin (17.41%) than 69.09% of its industry peers.
- In the last couple of years the Profit Margin of ZEG has grown nicely.
- Looking at the Operating Margin, with a value of 23.86%, ZEG is in line with its industry, outperforming 58.18% of the companies in the same industry.
- In the last couple of years the Operating Margin of ZEG has grown nicely.
- ZEG's Gross Margin of 81.31% is amongst the best of the industry. ZEG outperforms 85.45% of its industry peers.
- ZEG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.86% | ||
| PM (TTM) | 17.41% | ||
| GM | 81.31% |
OM growth 3Y6.24%
OM growth 5Y7.63%
PM growth 3Y32.91%
PM growth 5Y7.71%
GM growth 3Y0.34%
GM growth 5Y0.28%
2. ZEG.DE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ZEG is still creating some value.
- ZEG has about the same amout of shares outstanding than it did 1 year ago.
- Compared to 5 years ago, ZEG has more shares outstanding
- The debt/assets ratio for ZEG has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 3.77 indicates that ZEG is not in any danger for bankruptcy at the moment.
- ZEG's Altman-Z score of 3.77 is in line compared to the rest of the industry. ZEG outperforms 54.55% of its industry peers.
- The Debt to FCF ratio of ZEG is 3.42, which is a good value as it means it would take ZEG, 3.42 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of ZEG (3.42) is better than 63.64% of its industry peers.
- A Debt/Equity ratio of 0.55 indicates that ZEG is somewhat dependend on debt financing.
- ZEG has a Debt to Equity ratio of 0.55. This is in the better half of the industry: ZEG outperforms 61.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 3.42 | ||
| Altman-Z | 3.77 |
ROIC/WACC1.49
WACC9.14%
2.3 Liquidity
- ZEG has a Current Ratio of 0.94. This is a bad value and indicates that ZEG is not financially healthy enough and could expect problems in meeting its short term obligations.
- ZEG has a worse Current ratio (0.94) than 81.82% of its industry peers.
- A Quick Ratio of 0.72 indicates that ZEG may have some problems paying its short term obligations.
- With a Quick ratio value of 0.72, ZEG is not doing good in the industry: 74.55% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.72 |
3. ZEG.DE Growth Analysis
3.1 Past
- The earnings per share for ZEG have decreased by -1.34% in the last year.
- ZEG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.04% yearly.
- The Revenue has grown by 8.63% in the past year. This is quite good.
- ZEG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.15% yearly.
EPS 1Y (TTM)-1.34%
EPS 3Y6.74%
EPS 5Y15.04%
EPS Q2Q%-49.28%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y9.82%
Revenue growth 5Y17.15%
Sales Q2Q%4.11%
3.2 Future
- The Earnings Per Share is expected to grow by 15.20% on average over the next years. This is quite good.
- The Revenue is expected to grow by 6.82% on average over the next years.
EPS Next Y30.41%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
EPS Next 5Y15.2%
Revenue Next Year6.06%
Revenue Next 2Y5.93%
Revenue Next 3Y6.22%
Revenue Next 5Y6.82%
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. ZEG.DE Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 23.53, the valuation of ZEG can be described as rather expensive.
- The rest of the industry has a similar Price/Earnings ratio as ZEG.
- ZEG is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 18.05, ZEG is valued on the expensive side.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ZEG is on the same level as its industry peers.
- ZEG's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.53 | ||
| Fwd PE | 18.05 |
4.2 Price Multiples
- ZEG's Enterprise Value to EBITDA ratio is in line with the industry average.
- ZEG's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.09 | ||
| EV/EBITDA | 16.14 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of ZEG may justify a higher PE ratio.
- ZEG's earnings are expected to grow with 17.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.77
PEG (5Y)1.56
EPS Next 2Y20.69%
EPS Next 3Y17.63%
5. ZEG.DE Dividend Analysis
5.1 Amount
- ZEG has a Yearly Dividend Yield of 1.64%. Purely for dividend investing, there may be better candidates out there.
- ZEG's Dividend Yield is comparable with the industry average which is at 1.94.
- ZEG's Dividend Yield is comparable with the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
5.2 History
- The dividend of ZEG has a limited annual growth rate of 3.33%.
Dividend Growth(5Y)3.33%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 48.62% of the earnings are spent on dividend by ZEG. This is a bit on the high side, but may be sustainable.
- ZEG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP48.62%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
ZEG.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ZEG (2/5/2026, 7:00:00 PM)
160.7
+0.95 (+0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-10 2026-02-10/bmo
Earnings (Next)04-29 2026-04-29
Inst Owners49.17%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap249.13B
Revenue(TTM)58.74B
Net Income(TTM)10.22B
Analysts82.94
Price Target175.52 (9.22%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
Yearly Dividend2.7
Dividend Growth(5Y)3.33%
DP48.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.37%
Min EPS beat(2)-60.38%
Max EPS beat(2)9.64%
EPS beat(4)2
Avg EPS beat(4)-12.23%
Min EPS beat(4)-60.38%
Max EPS beat(4)9.64%
EPS beat(8)4
Avg EPS beat(8)-5.74%
EPS beat(12)7
Avg EPS beat(12)-2.63%
EPS beat(16)11
Avg EPS beat(16)-0.36%
Revenue beat(2)1
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-4.83%
Max Revenue beat(2)2.2%
Revenue beat(4)1
Avg Revenue beat(4)-2.92%
Min Revenue beat(4)-5.08%
Max Revenue beat(4)2.2%
Revenue beat(8)4
Avg Revenue beat(8)-0.54%
Revenue beat(12)5
Avg Revenue beat(12)-0.86%
Revenue beat(16)6
Avg Revenue beat(16)-0.78%
PT rev (1m)5.49%
PT rev (3m)12.4%
EPS NQ rev (1m)-1.75%
EPS NQ rev (3m)-1.48%
EPS NY rev (1m)1.58%
EPS NY rev (3m)-0.37%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-0.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.53 | ||
| Fwd PE | 18.05 | ||
| P/S | 5.03 | ||
| P/FCF | 34.09 | ||
| P/OCF | 20.28 | ||
| P/B | 6.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.14 |
EPS(TTM)6.83
EY4.25%
EPS(NY)8.9
Fwd EY5.54%
FCF(TTM)4.71
FCFY2.93%
OCF(TTM)7.93
OCFY4.93%
SpS31.94
BVpS26.46
TBVpS-5.67
PEG (NY)0.77
PEG (5Y)1.56
Graham Number63.77
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 21.01% | ||
| ROCE | 16.8% | ||
| ROIC | 13.63% | ||
| ROICexc | 14.63% | ||
| ROICexgc | 59.47% | ||
| OM | 23.86% | ||
| PM (TTM) | 17.41% | ||
| GM | 81.31% | ||
| FCFM | 14.76% |
ROA(3y)7.2%
ROA(5y)5.03%
ROE(3y)17.82%
ROE(5y)12.53%
ROIC(3y)12.48%
ROIC(5y)10.5%
ROICexc(3y)13.49%
ROICexc(5y)11.39%
ROICexgc(3y)81.92%
ROICexgc(5y)83.55%
ROCE(3y)15.36%
ROCE(5y)12.92%
ROICexgc growth 3Y-25.55%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y9.13%
ROICexc growth 5Y9.72%
OM growth 3Y6.24%
OM growth 5Y7.63%
PM growth 3Y32.91%
PM growth 5Y7.71%
GM growth 3Y0.34%
GM growth 5Y0.28%
F-Score7
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 3.42 | ||
| Debt/EBITDA | 1.36 | ||
| Cap/Depr | 103% | ||
| Cap/Sales | 10.05% | ||
| Interest Coverage | 10.65 | ||
| Cash Conversion | 73.79% | ||
| Profit Quality | 84.79% | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 3.77 |
F-Score7
WACC9.14%
ROIC/WACC1.49
Cap/Depr(3y)80.57%
Cap/Depr(5y)64.46%
Cap/Sales(3y)8.93%
Cap/Sales(5y)7.69%
Profit Quality(3y)99.49%
Profit Quality(5y)775.68%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.34%
EPS 3Y6.74%
EPS 5Y15.04%
EPS Q2Q%-49.28%
EPS Next Y30.41%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
EPS Next 5Y15.2%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y9.82%
Revenue growth 5Y17.15%
Sales Q2Q%4.11%
Revenue Next Year6.06%
Revenue Next 2Y5.93%
Revenue Next 3Y6.22%
Revenue Next 5Y6.82%
EBIT growth 1Y10.05%
EBIT growth 3Y16.67%
EBIT growth 5Y26.09%
EBIT Next Year23.4%
EBIT Next 3Y12.45%
EBIT Next 5Y11.39%
FCF growth 1Y19.18%
FCF growth 3Y6.21%
FCF growth 5Y31.64%
OCF growth 1Y22.88%
OCF growth 3Y14.12%
OCF growth 5Y24.88%
ASTRAZENECA PLC / ZEG.DE Fundamental Analysis FAQ
What is the fundamental rating for ZEG stock?
ChartMill assigns a fundamental rating of 5 / 10 to ZEG.DE.
What is the valuation status of ASTRAZENECA PLC (ZEG.DE) stock?
ChartMill assigns a valuation rating of 3 / 10 to ASTRAZENECA PLC (ZEG.DE). This can be considered as Overvalued.
What is the profitability of ZEG stock?
ASTRAZENECA PLC (ZEG.DE) has a profitability rating of 7 / 10.
What is the valuation of ASTRAZENECA PLC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ASTRAZENECA PLC (ZEG.DE) is 23.53 and the Price/Book (PB) ratio is 6.07.
Can you provide the expected EPS growth for ZEG stock?
The Earnings per Share (EPS) of ASTRAZENECA PLC (ZEG.DE) is expected to grow by 30.41% in the next year.